Literature DB >> 11781619

Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts.

K Theilgaard-Mönch1, K Raaschou-Jensen, H Palm, K Schjødt, C Heilmann, L Vindeløv, N Jacobsen, E Dickmeiss.   

Abstract

Currently, bone marrow (BM), cord blood (CB), and G-CSF-mobilized peripheral blood progenitor cells (PBPCs) are the most commonly used sources for allogeneic stem cell transplantation (SCT). The aim of this study was to assess the yields and distribution of lymphocyte subsets, lymphocyte progenitors and hematopoietic stem cells (HSC) in each type of allograft by three-color flow cytometry. The yields of CD34(+)CD38(-) HSCs did not differ significantly between BM grafts (2.80 +/- 0.74 x 10(6)) and leukapheresis products (LPs) (1.82 +/- 0.64 x 10(6)), and were lowest in CB grafts (0.21 +/- 0.05 x 10(6)). For most lymphocyte subsets yields were lowest in CB grafts and significantly higher in LPs than in BM grafts. BM grafts, however, contained the highest yields of CD34(+)CD19(+)CD20(-) B cell progenitors and CD19(+)CD20(-) B cells. The relative frequencies of the naive CD45RA(+)CD45RO(-) phenotype among CD4(+) and CD8(high) T cells were highest in CB grafts (P < or = 0.001), and higher in LPs than in BM grafts (P < or = 0.02). The latter finding was in accordance with a preferential G-CSF mobilization of naive T cells relative to the total lymphocyte population (P < or = 0.014). CD3(+)CD8(low) and CD3(+)CD8(low)CD4(-) subsets, which facilitate engraftment in murine transplantation models, demonstrated a tendency towards lower frequencies among T cells in CB grafts and LPs compared to BM grafts. This observation coincided with a significantly reduced mobilization of subsets potentially enriched for facilitating cells as compared to the total lymphocyte population (P < or = 0.036). The CD34(+) compartment of CB grafts contained a significantly higher percentage (12.1%) of CD34(+)CD7(+)CD3(-) T cell progenitors than those of BM grafts (5.1%) and LPs (3.6%). In addition, CB lymphocytes contained the highest fraction of CD3(-)CD16/56(+) NK cells (P < or = 0.013) and almost no CD3(+)CD16/56(+) NKT cells (P < 0.001) compared to adult cell sources. In summary, LPs, CB allografts and BM allografts differ widely with respect to the cellular composition of their lymphocyte compartments, which is partially affected by a varying mobilization efficiency of G-CSF for distinct lymphocyte subsets.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11781619     DOI: 10.1038/sj.bmt.1703270

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  20 in total

Review 1.  Transplantation of umbilical cord blood stem cells for treating spinal cord injury.

Authors:  Dong-Hyuk Park; Jeong-Hyun Lee; Cesario V Borlongan; Paul R Sanberg; Yong-Gu Chung; Tai-Hyoung Cho
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

2.  T cell activation in utero: self or non-self discrimination.

Authors:  Adriana Bonomo; Wilson Savino
Journal:  Ann Transl Med       Date:  2015-04

3.  I.v. BU/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high-risk hematological diseases.

Authors:  H Yamamoto; N Uchida; N Matsuno; A Kon; A Nishida; H Ota; T Ikebe; N Nakano; K Ishiwata; H Araoka; S Takagi; M Tsuji; Y Asano-Mori; G Yamamoto; K Izutsu; K Masuoka; A Wake; A Yoneyama; S Makino; S Taniguchi
Journal:  Bone Marrow Transplant       Date:  2015-01-26       Impact factor: 5.483

Review 4.  The Interaction Between Niche and Hematopoietic Stem Cells.

Authors:  Chaoyu Wang; Chen Tian; Yizhuo Zhang
Journal:  Indian J Hematol Blood Transfus       Date:  2016-01-12       Impact factor: 0.900

5.  The number of CD34+CD133+ hematopoietic stem cells residing in umbilical cord blood (UCB) units is not correlated with the numbers of total nucleated cells and CD34+ cells: a possible new indicator for quality evaluation of UCB units.

Authors:  Yoshikazu Matsuoka; Fumiaki Nakamura; Kazuo Hatanaka; Tatsuya Fujioka; Satoshi Otani; Takafumi Kimura; Yoshihiro Fujimura; Hiroaki Asano; Yoshiaki Sonoda
Journal:  Int J Hematol       Date:  2018-07-25       Impact factor: 2.490

6.  Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA+ Metastatic Colorectal Cancers.

Authors:  Chengcheng Zhang; Zhe Wang; Zhi Yang; Meiling Wang; Shiqi Li; Yunyan Li; Rui Zhang; Zhouxing Xiong; Zhihao Wei; Junjie Shen; Yongli Luo; Qianzhen Zhang; Limei Liu; Hong Qin; Wei Liu; Feng Wu; Wei Chen; Feng Pan; Xianquan Zhang; Ping Bie; Houjie Liang; Gabriele Pecher; Cheng Qian
Journal:  Mol Ther       Date:  2017-03-31       Impact factor: 11.454

7.  Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation.

Authors:  Caron A Jacobson; Amin T Turki; Sean M McDonough; Kristen E Stevenson; Haesook T Kim; Grace Kao; Maria I Herrera; Carol G Reynolds; Edwin P Alyea; Vincent T Ho; John Koreth; Philippe Armand; Yi-Bin Chen; Karen Ballen; Robert J Soiffer; Joseph H Antin; Corey S Cutler; Jerome Ritz
Journal:  Biol Blood Marrow Transplant       Date:  2011-08-26       Impact factor: 5.742

8.  Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation.

Authors:  Mark Bosch; Manveer Dhadda; Mette Hoegh-Petersen; Yiping Liu; Laura M Hagel; Peter Podgorny; Alejandra Ugarte-Torres; Faisal M Khan; Joanne Luider; Iwona Auer-Grzesiak; Adnan Mansoor; James A Russell; Andrew Daly; Douglas A Stewart; David Maloney; Michael Boeckh; Jan Storek
Journal:  Cytotherapy       Date:  2012-09-18       Impact factor: 5.414

9.  The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes.

Authors:  Nancy H Collins; Adrian P Gee; April G Durett; Fangyu Kan; Mei-Jie Zhang; Richard E Champlin; Dennis Confer; Mary Eapen; Alan Howard; Roberta King; Mary J Laughlin; Robert J Plante; Michelle Setterholm; Stephen Spellman; Carolyn Keever-Taylor; John E Wagner; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2009-10-12       Impact factor: 5.742

Review 10.  The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells.

Authors:  Michael R Verneris; Jeffrey S Miller
Journal:  Br J Haematol       Date:  2009-10       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.